Related Experiment Video
Updated: May 26, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
p53 protein expression in chronic lymphocytic leukemia
Ludger Sellmann1, Alexander Carpinteiro, Holger Nückel
1Department of Hematology, Medical Faculty, University of Duisburg-Essen, Essen, Germany. ludger.sellmann@uk-essen.de
Altered p53 protein levels and isoform ratios in chronic lymphocytic leukemia (CLL) correlate with poorer outcomes. Even without 17p13 deletions, these changes impact CLL development and suggest new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- The p53 pathway is frequently altered in chronic lymphocytic leukemia (CLL).
- These alterations are often linked to 17p13 deletions or TP53 gene mutations.
- The role of p53 isoforms in CLL pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the impact of full-length p53 and its isoforms (β and γ) protein expression in CLL.
- To correlate p53 protein expression and isoform ratios with clinical outcomes in CLL patients.
- To examine alterations in p53 isoform expression in CLL compared to normal B-cells.
Main Methods:
- Protein expression analysis of full-length p53 and its isoforms β and γ.
- Investigation of 103 chronic lymphocytic leukemia (CLL) samples.
- Correlation analysis between p53 expression, 17p13 deletions, and clinical data (treatment-free survival, overall survival).
Main Results:
- A strong correlation was found between 17p13 deletions and accumulation of full-length p53 protein, associated with worse outcomes.
- Relative expression levels of p53 isoforms were significantly altered in CLL compared to normal B-cells, even without 17p13 deletions.
- Higher p53 protein ratios in CLL correlated with worse clinical courses.
Conclusions:
- Differential expression of p53 isoforms disrupts the p53 response in CLL.
- Altered p53 isoform expression contributes to CLL pathogenesis.
- p53 isoform analysis may offer prognostic value and potential therapeutic targets in CLL.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway

